SAN FRANCISCO -- Researchers report positive results from a Phase I/II clinical trial of a novel anti-cancer drug which offers two modes of action. In 26 patients with advanced solid tumors, treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results